Egyptian Drug Authority signs cooperation protocol to enhance training in the medical sector
The activities of the fifth edition of the Africa Health ExCon 2026 witnessed a new step aimed at developing the health sector in Egypt. The Egyptian Drug Authority signed an important cooperation protocol with GlaxoSmithKline Egypt, as part of the state's ongoing efforts to support the pharmaceutical industries.
This protocol primarily aims to enhance training and professional development programs for workers in the pharmaceutical sector. Through this partnership, the Authority seeks to raise the efficiency of human resources, which contributes to providing better health services to citizens and developing the skills of those working in this vital field.
This step comes at a time when Egypt is paying great attention to localizing the pharmaceutical industry and developing medical technology. The Africa Health ExCon is an important platform for exchanging expertise between global companies and Egyptian institutions, which helps in attracting investments and supporting innovation in the healthcare field.
It is expected that this cooperation will lead to an improvement in the quality of technical and professional training, which will positively reflect on the quality of medicines available in the Egyptian market. The Egyptian Drug Authority confirms that such partnerships are part of its strategy to ensure the availability of safe and effective medicines for patients across the Republic.
In conclusion, this agreement represents a model of cooperation between the government sector and international companies, which strengthens Egypt's position as a regional hub for medical and pharmaceutical industries on the African continent.